IN8BIO, INC. Segment Reporting Other Item Amount
IN8BIO, INC. (INAB) reported Segment Reporting Other Item Amount of $780.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-06
- IN8BIO, INC. segment reporting other item amount for the quarter ending 2026-06-30 was $780.00K, a 7.59% increase year-over-year.
- IN8BIO, INC. segment reporting other item amount for the quarter ending 2026-03-31 was $671.00K, a 27.14% decline year-over-year.
- IN8BIO, INC. segment reporting other item amount for the quarter ending 2025-12-31 was $535.00K, a 34.52% decline year-over-year.
- IN8BIO, INC. segment reporting other item amount for the quarter ending 2025-09-30 was $629.00K, a 61.92% decline year-over-year.
- IN8BIO, INC. segment reporting other item amount for fiscal 2025 was $2.81M, a 31.21% decline from fiscal 2024.
- IN8BIO, INC. segment reporting other item amount for fiscal 2024 was $4.08M, a 41.55% increase from fiscal 2023.
- IN8BIO, INC. segment reporting other item amount for fiscal 2023 was $2.89M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $780.00K 10-Q · filed 2026-08-06 | $1.45M 10-Q · filed 2026-08-06 | $1.99M derived: sum of 3 quarters · filed 2026-08-06 | $2.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $671.00K 10-Q · filed 2026-05-07 | $1.21M derived: sum of 2 quarters · filed 2026-05-07 | $1.83M derived: sum of 3 quarters · filed 2026-05-07 | $2.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.16M derived: sum of 2 quarters · filed 2026-03-12 | $1.89M derived: sum of 3 quarters · filed 2026-08-06 | $2.81M 10-K · filed 2026-03-12 |
| 2025-09-30 | $629.00K 10-Q · filed 2025-11-06 | $1.35M derived: sum of 2 quarters · filed 2026-08-06 | $2.27M 10-Q · filed 2025-11-06 | $3.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $725.00K 10-Q · filed 2026-08-06 | $1.65M 10-Q · filed 2026-08-06 | $2.46M derived: sum of 3 quarters · filed 2026-08-06 | $4.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $921.00K 10-Q · filed 2026-05-07 | $1.74M derived: sum of 2 quarters · filed 2026-05-07 | $3.39M derived: sum of 3 quarters · filed 2026-05-07 | $4.07M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $2.47M derived: sum of 2 quarters · filed 2026-03-12 | $3.15M derived: sum of 3 quarters · filed 2026-03-12 | $4.08M 10-K · filed 2026-03-12 |
| 2024-09-30 | $1.65M 10-Q · filed 2025-11-06 | $2.33M derived: sum of 2 quarters · filed 2025-11-06 | $3.27M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $683.00K 10-Q · filed 2025-08-07 | $1.62M derived: sum of 2 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $933.00K 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $2.89M 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |